Adherence to modern technologies of glycemic management in diabetic patients

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Diabetes mellitus (DM) is a chronic metabolic disorder characteristic of a global pathology that entails hyperglycemia and complications at both the micro- and macrolevels. According to the World Health Organization (WHO), about 600 million people worldwide suffer from diabetes today, and the number of such patients will increase to 1.5 billion by 2050. In Russia, there are 10-12 million diabetic patients, and about half of them remain undiagnosed (according to the materials of the A.I. Yevdokimov Moscow State University of Medicine and Dentistry, during a speech at the XXXI Russian National Congress «Man and Medicine»). The main share falls on type 2 diabetes mellitus, which is widespread and accounts for 90% of cases. In light of the continuous increase in the number of people with diabetes, the need for sufficient and high-quality glycemia monitoring has increased dramatically, prompting the creation of new methods for monitoring blood glucose levels. Maintaining glycemic concentrations in the target range is necessary to prevent serious complications. Optimization of the glycemic profile is becoming a key factor in successful diabetes management. This literature review is devoted to the analysis of adherence to modern methods of glucose control in diabetic patients with, including the identification of significant aspects and influencing factors.

Full Text

Restricted Access

About the authors

N. A. Chernikova

Russian Medical Academy of Continuous Professional Education; Central Clinical Hospital of Civil Aviation

Author for correspondence.
Email: nachendoc@yandex.ru
ORCID iD: 0000-0002-0562-8396

Cand. Sci. (Med.), Associate Professor at the Department of Endocrinology; Head of the Endocrinology Department

Russian Federation, Moscow; Moscow

K. S. Prokhorova

Russian Medical Academy of Continuous Professional Education

Email: nachendoc@yandex.ru
Russian Federation, Moscow

I. M. Gancho

Russian Medical Academy of Continuous Professional Education

Email: nachendoc@yandex.ru
Russian Federation, Moscow

References

  1. Azzam M.M., Ibrahim A.A., Abd El-Ghany M.I. Factors affecting glycemic control among Egyptian people with diabetes attending primary health care facilities in Mansoura District. Egypt J Crit Care. 2021;33:33..
  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018. American Diabetes Association. Diabetes Care. 2018 Jan;41(Suppl 1):S13–S27. doi: 10.2337/dc18-S002.
  3. Gonzalez Clemente J.M., Llaurado Cabot G. Assessment of glycemic control: new insights into the evaluation of the diabetic patient. Med Clin. (Barc). 2010;135:15–9. doi: 10.1016/S0025-7753(10)70028-2.
  4. Monnier L., Colette C. Target for glycemic control: concentrating on glucose. Diab Care. 2009;32(Suppl. 2):S199–204. doi: 10.2337/dc09-S310.
  5. Lloyd A., Sawyer W., Hopkinson P. Impact of long-term complications on quality of life in patients with type 2 diabetes not using insulin. Value Health. 2001;4:392–400. doi: 10.1046/j.1524-4733.2001.45029.x.
  6. LeRoith D., Smith D.O. Monitoring glycemic control: the cornerstone of diabetes care. Clin Ther. 2005;27:1489–99. doi: 10.1016/j.clinthera.2005.10.010.
  7. Fiseha T., Alemayehu E., Kassahun W., et al. Factors associated with glycemic control among diabetic adult out-patients in Northeast Ethiopia. BMC. Res Notes. 2018;11:316. doi: 10.1186/s13104-018-3423-5.
  8. Yigazu D.M., Desse T.A. Glycemic control and associated factors among type 2 diabetic patients at Shanan Gibe Hospital, Southwest Ethiopia. BMC. Res Notes. 2017;10:597. doi: 10.1186/s13104-017-2924-y.
  9. Abdissa D., Hirpa D. Poor glycemic control and its associated factors among diabetes patients attending public hospitals in West Shewa Zone, Oromia, Ethiopia: An Institutional based cross-sectional study. Metab Open. 2022;13:100154. doi: 10.1016/j.metop.2021.100154.
  10. Liberati A., Altman D.G., Tetzlaff J., et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:1–34. doi: 10.1016/j.jclinepi.2009.06.006.
  11. Bereda G., Bereda G. The incidence and predictors of poor glycemic control among adults with type 2 diabetes mellitus in ambulatory clinic of Mettu Karl referral hospital, south western, Ethiopia: a prospective cross sectional study. Int Arch Endocrinol Clin. Res. 2021;7:24.
  12. Черникова Н.А. Современные возможности управления сахарным диабетом. Эффективная фармакотерапия. 2023;19(12):52–56. [Chernikova N.A. Modern Possibilities of Diabetes Mellitus Management. 2023;19(12):52–56. Effective pharmacotherapy. (In Russ.)]. doi: 10.33978/2307-3586-2023-19-12-52-56.
  13. Бирюкова Е.В., Шинкин М.В., Соловьева И.В. Современная практика самоконтроля гликемии: основы эффективного управления сахарным диабетом. Клинический разбор в общей медицине. 2023;4(2):60–67. [Biryukova E.V., Shinkin M.V., Solovieva I.V. Modern practice of glycemic self-monitoring: fundamentals of effective diabetes management. Clinical review for general practice. 2023;4(2):60–67. doi: 10.47407/kr2023.4.2.00205.
  14. Мельниченко Г.А., Дедов И.И., Белая Ж.Е. и др. Болезнь Иценко-Кушинга: клиника, диагностика, дифференциальная диагностика, методы лечения. Проблемы эндокринологии. 2015;61(2):55–77. [Melnichenko G.A., Dedov I.I., Belaya Z.E., et al. Cushing’s disease: the clinical features, diagnostics, differential diagnostics, and methods of treatment. Probl Endocrinol. 2015;61(2):55–77. (In Russ.)]. doi: 10.14341/probl201561255-77.
  15. Черникова Н.А. Эволюция непрерывного мониторирования глюкозы в современных клинических рекомендациях для пациентов с сахарным диабетом. Эндокринология: новости, мнения, обучение. 2020;9(4):59–65. [Chernikova N.A. Evolution of continuous glucose monitoring in existing clinical guidelines for patient with diabetes mellitus. Endocrinol: News Opin Train. 2020;9(4):59–65. (In Russ.)]. doi: 10.33029/2304-9529- 2020-9-4-59-65.
  16. Анциферов М.Б., Демидов Н.А., Котешкова О.М. и др. Оценка вариабельности уровня гликемии на основе самоконтроля. Результаты пилотного проекта. Эндокринология: новости, мнения, обучение. 2021;10(2):26–31. [Antsiferov M.B., Demidov N.A., Koteshkova O.M., et al. Assessment of the variability of glycemic levels based on self-control. Pilot project results. Endocrinol: News Opin Train. 2021;10(2):26–31. (In Russ.)]. doi: 10.33029/2304-9529-2021-10-2-26-31.
  17. Белая Ж.Е., Рожинская Л.Я., Мельниченко Г.А. и др. Роль градиента пролактина и АКТГ/пролактин-нормализованного отношения для повышения чувствительности и специфичности селективного забора крови из нижних каменистых синусов для дифференциальной диагностики АКТГ-зависимого гиперкортицизма. Проблемы эндокринологии. 2013;59(4):3–10. [Belaya Z.E., Rozhinskaia L.I., Mel’nichenko G.A., et al. The role of prolactin gradient and normalized ACTH/prolactin ratio in the improvement of sensi- tivity and specificity of selective blood sampling from inferior petrosal sinuses for differential diagnostics of ACTH-dependent hypercorticism. Problemy Endocrinologii. 2013;59(4):3–10. (In Russ.)]. Doi: 10.14341/ probl20135943-10.
  18. Черникова Н.А., Григорьева М.А. Современные подходы к управлению гликемией у пациентов с сахарным диабетом. РМЖ. Медицинское обозрение. 2023;7(9):592–597. [Chernikova N.A., Grigorieva M.A. Modern methods aimed at glycemia management in patients with diabetes mellitus. Russian Medical Inquiry. 2023;7(9):592–597. (In Russ.)]. doi: 10.32364/2587-6821-2023-7-9-6.
  19. Прожерина Ю. «Умные» глюкометры – революция в управлении диабетом. Ремедиум. 2021(1):43–45. [Prozherina Yu. Smart glucometers: revolution in diabetes management. Remedium. 2021(1):43–45. (In Russ.)]. doi: 10.21518/1561-5936-2021-1-43-45.
  20. Fisher L., Fortmann A., Stuhr A. Can a Basic Management App Paired With A Glucose Meter Help Reduce Glucose Levels Among Adults With Type 2 Diabetes? The REALL Study. J Diabetes Sci Techno.2024;18(1):99-105. doi: 10.1177/19322968221096163.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1. Mortality from diabetes mellitus in Russia

Download (102KB)
Indexing metadata
3. Fig. 2. System for independent sensor readout

Download (38KB)
Indexing metadata
4. Fig. 3. Glucometers with automatic data transfer to the mobile application

Download (29KB)
Indexing metadata
5. Fig. 4. Top 3 corporations in the market of glucometers (including kits) and test strips at the end of 2020 and the compound annual growth rate (CAGR) of their sales over the period 2018-2020, rubles

Download (41KB)
Indexing metadata
6. Fig. 5. Blood glucose level data for Patient A. (Contour Diabetes application)

Download (399KB)
Indexing metadata

Copyright (c) 2024 Bionika Media